Cargando…

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization

BACKGROUND: To confirm the prognostic value of previously published baseline interleukin 6 (IL6) and IL8 cutoff values in survival and liver dysfunction in patients with advanced HCC undergoing (90)Y radioembolization. METHODS: A total of 83 patients (77 male) represented a subset of HCC patients un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Öcal, Osman, Kupčinskas, Juozas, Morkunas, Egidijus, Amthauer, Holger, Schütte, Kerstin, Malfertheiner, Peter, Klümpen, Heinz Josef, Sengel, Christian, Benckert, Julia, Seidensticker, Ricarda, Sangro, Bruno, Wildgruber, Moritz, Pech, Maciej, Bartenstein, Peter, Ricke, Jens, Seidensticker, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172845/ https://www.ncbi.nlm.nih.gov/pubmed/34080071 http://dx.doi.org/10.1186/s13550-021-00791-w

Ejemplares similares

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
por: Öcal, Osman, et al.
Publicado: (2022)

Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
por: Seidensticker, Ricarda, et al.
Publicado: (2018)

The Impact of Unilateral (90)Y-radioembolization on Functional Changes in the Contralateral Hepatic Lobe: The Prospective, Open-label RadioEmbolization, Volumetry, and Liver FuncTion Measurements (REVoluTion) Study
por: Garlipp, Benjamin, et al.
Publicado: (2021)

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
por: Seidensticker, Max, et al.
Publicado: (2023)

Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
por: Surov, Alexey, et al.
Publicado: (2023)

Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system
por: Damm, Robert, et al.
Publicado: (2016)

Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization
por: Seidensticker, Max, et al.
Publicado: (2021)

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial
por: Shuen, Timothy Wai Ho, et al.
Publicado: (2022)

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2021)

Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma
por: Seidensticker, Ricarda, et al.
Publicado: (2016)

Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients
por: Saalfeld, Sylvia, et al.
Publicado: (2023)

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity
por: Seidensticker, Max, et al.
Publicado: (2014)

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
por: Öcal, Osman, et al.
Publicado: (2022)

Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
por: Seidensticker, Max, et al.
Publicado: (2011)

Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial
por: Damm, Robert, et al.
Publicado: (2023)

Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression
por: Öcal, Osman, et al.
Publicado: (2022)

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2019)

Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)
por: Seidensticker, Max, et al.
Publicado: (2015)

Bi-Centric Independent Validation of Outcome Prediction after Radioembolization of Primary and Secondary Liver Cancer
por: Fabritius, Matthias Philipp, et al.
Publicado: (2021)

Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases
por: Seidensticker, Max, et al.
Publicado: (2010)

Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma
por: Öcal, Osman, et al.
Publicado: (2021)

Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases
por: Damm, Robert, et al.
Publicado: (2022)

Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases
por: Rühl, Ricarda, et al.
Publicado: (2010)

Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial
por: Geyer, Thomas, et al.
Publicado: (2022)

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving (90)Y-radioembolization
por: Hirner-Eppeneder, Heidrun, et al.
Publicado: (2023)

Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
por: Schütte, Kerstin, et al.
Publicado: (2014)

Do We Really Need Expensive Stent-Grafts to Treat External Iliac Artery Lesions Effectively?
por: Öcal, Osman, et al.
Publicado: (2023)

Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access
por: Mansour, Nabeel, et al.
Publicado: (2022)

Gut microbial similarity in twins is driven by shared environment and aging
por: Vilchez-Vargas, Ramiro, et al.
Publicado: (2022)

(68)Ga-DOTATATE PET/CT and MRI with Diffusion-Weighted Imaging (DWI) in Short- and Long-Term Assessment of Tumor Response of Neuroendocrine Liver Metastases (NELM) Following Transarterial Radioembolization (TARE)
por: Ingenerf, Maria, et al.
Publicado: (2021)

Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience
por: Drewes, Ralph, et al.
Publicado: (2019)

Percutaneous transhepatic biliary drainage (PTBD) in patients with biliary leakage: Technical and clinical outcomes
por: Deniz, Sinan, et al.
Publicado: (2023)

Efficacy and safety of image-guided interstitial single fraction high-dose-rate brachytherapy in the management of metastatic malignant melanoma
por: Bretschneider, Tina, et al.
Publicado: (2015)

Improvement of Contrast Media Enhancement in CTA Evaluating Pulmonary Embolism by Utilizing ‘Delayed’ Bolus Tracking in the Descending Aorta
por: Damm, Robert, et al.
Publicado: (2016)

Artifact characterization of Nitinol needles in magnetic resonance imaging-guided musculoskeletal interventions at 3.0 tesla: a phantom study
por: Schmidt, Vanessa Franziska, et al.
Publicado: (2023)

Percutaneous Sclerotherapy of Venous Malformations of the Hand: A Multicenter Analysis
por: Schmidt, Vanessa F., et al.
Publicado: (2021)

Image-guided embolization of arteriovenous malformations of the hand using Ethylene-vinyl Alcohol Copolymer
por: Schmidt, Vanessa F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hukr7v9cslaei6noogo894n5as